ArticleDrug design, development and therapy2026

Single-Cell Transcriptomics Reveals Riluzole as an Osteoarthritis Candidate Drug via OB-NE Signaling Modulation and CTSS/NOS1 Inhibition.

Kun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.